Company Financials

Adaptive Biotechnologies Corporation Financials

United States dollar

business Adaptive Biotechnologies Corporation Company Profile

Main Stock Listing

NASDAQ: ADPT

Market Capitalization $2.43 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -14.73
Forward PE -27.70
Price to Sales TTM $9.61
Price to Book MRQ $11.87
Enterprise to Revenue 9.61
Enterprise to EBITDA -40.43

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -31.50%
Operating Margin 10.95%
Return on Assets TTM -9.32%
Return on Equity TTM -37.21%

Income Statement

Revenue TTM $252,754,000
Revenue per Share TTM $1.68
Quarterly Revenue Growth 102.40%
Gross Profit TTM $164,492,992
EBITDA $-60,101,000
Net Income to Common TTM $-79,612,000
Diluted EPS TTM $-0.52
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $212,768,992
Total Cash per Share MRQ $1.39
Total Debt MRQ $
Total Debt to Equity MRQ 104.60
Current Ratio MRQ 3.38
Book Value per Share MRQ $1.34

Cash Flow

Operating Cash Flow TTM $-60,532,000
Levered Free Cash Flow TTM $1,285,125

ADPT Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 152,581,042
Float Shares 117,933,858
Avg 10 Volume 1,838,780
Avg 30 Volume None
Shares Short 9,742,510
Short Ratio 3.12
Short % of Shares 8.17%
% Held by Insiders 2.07%
% Held by Institutions 96.82%

Stock Price Summary

Beta 2.20
Fifty Two Week Low $5.98
Fifty Two Week High $20.76
Fifty Two Week Change 55.69%
Day 50 MA $16.53
Day 200 MA $12.34

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date